‘Innovation needs to become part of our DNA’ – changes at the top at Novus
Novus International, Inc., recently announced changes to its corporate structure, with the areas of innovation and R&D becoming even more prominent in the organization.
Alfred Zimmerman is joining the executive leadership team as chief innovation officer.
“Innovation needs to become part of our DNA,” said CEO, Dan Meagher. “It is an integral part of our long-term strategic plans and must be elevated within the organization.”
Zimmerman has been with Novus since 2015, most recently serving as senior director of strategic innovation and project management. He was instrumental in the partnership with biotechnology company, Agrivida, which was announced in January.
In the new role, Zimmerman will work with the company’s R&D teams to identify ways to grow the specialty product line while also looking outside Novus for opportunities to bring new technologies and services to customers.
He said he is aiming to instill an innovative mindset in his colleagues.
“Innovation is more than just products,” Zimmerman said. “It’s bringing new thoughts and direction to our technologies and capabilities as an organization.”
Uwe Ranft has also been named as chief strategic marketing and technology officer. In this role, Ranft will focus on strengthening the company’s strategic marketing and technical service teams and oversee the strategic accounts business.
Ranft has been with Novus for 17 years and most recently served as vice president and chief commercial officer CCO for Europe, Middle East, and Africa (EMEA).
With Ranft stepping away from that role, Ed Galo, currently vice president and CCO for Americas, will take on the role of chief commercial officer for EMEA as well.
